Regulation & law · 28/09/2001

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Live Attenuated Virus Vaccine for Western Equine Encephalitis Virus, Eastern Equine Encephalitis Virus, and Venezuelan Equine Encephalitis Virus IE and IIIA Variants

The U.S. Patent Office is announcing the availability for licensing of a patent for a live attenuated virus vaccine against Western Equine Encephalitis Virus, Eastern Equine Encephalitis Virus, and Venezuelan Equine Encephalitis Virus IE and IIIA Variants. The patent, issued on July 17, 2001, has been assigned to the U.S. Government.